Fresenius Medical Care Q1 Revenue Falls 6% on Weak Dollar

FRESENIUS MEDICAL CARE AG revenue fell 6% to 4.61 billion euros ($5.39 billion) during the first quarter of 2026. This result matched Vara Research analyst expectations of 4.59 billion euros despite headwinds from divestitures. Investors are assessing how currency volatility impacts the dialysis provider's ability to maintain stable margins in its largest markets.

### Currency Pressure and Portfolio Shifts A weak United States dollar reduced the value of North American earnings when converted to euros. The EUR/USD exchange rate fluctuations and recent asset sales were the primary drivers of the 6% revenue decline. Fresenius Medical Care reported these figures on May 5, noting the results align with its broader restructuring goals.